Fasson technology's "inhaled new crown vaccine" was approved by the State Food and Drug Administration
Time：
In March 23rd, Conchino bio announced at the HKEx that its inhaled recombinant New Coronavirus vaccine was approved by the State Administration of drugs for clinical trials.
